Stock SGBCF SHANGHAI HENLIUS BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Shanghai Henlius Biotech, Inc. OTC Markets

Equities

SGBCF

CNE100003N76

Delayed OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Shanghai Henlius Biotech, Inc. -.--% -.--%
05-24 Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation MT
05-24 Henlius' EU Marketing Application for Denosumab Biosimilar Accepted and Validated by Regulator MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SHANGHAI HENLIUS BIOTECH, INC. Stock Shanghai Henlius Biotech, Inc.
 1.31B - -
CSL LIMITED Stock CSL Limited
 92.26B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 38.11B
BIOGEN INC. Stock Biogen Inc.
 32.9B
UCB Stock UCB
 26.51B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 15.75B
  1. Stock Market
  2. Equities
  3. 2696 Stock
  4. SGBCF Stock
  5. Charts Shanghai Henlius Biotech, Inc.
  6. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW